Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
216.91-2.08 (-0.95%)
At close: 04:00PM EST
216.98 +0.07 (+0.03%)
After hours: 04:30PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close218.99
Open217.32
Bid210.00 x 800
Ask224.29 x 1000
Day's Range215.17 - 220.00
52 Week Range173.45 - 428.00
Volume775,473
Avg. Volume1,591,174
Market Cap34.12B
Beta (5Y Monthly)1.17
PE Ratio (TTM)48.85
EPS (TTM)4.44
Earnings DateFeb 08, 2023 - Feb 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est248.35
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ILMN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Illumina, Inc.
    Analyst Report: Illumina, Inc.Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
    Rating
    Fair Value
    Economic Moat
    24 days agoMorningstar
View more
  • Insider Monkey

    10 Best Biotech Stocks To Buy According To Hedge Funds

    In this article, we discuss 10 best biotech stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Biotech Stocks To Buy According To Hedge Funds. In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, […]

  • ACCESSWIRE

    Addressing the Shortage of Genetic Counselors With Software

    NORTHAMPTON, MA / ACCESSWIRE / November 21, 2022 / Illumina: Nearly everyone is a carrier for some kind of genetic disorder.1 (Probably even you.) Being a carrier means you inherited an abnormal copy of a gene from one parent, but you show no symptoms ...

  • ACCESSWIRE

    Q&A With the CTO: Storing Growing Data While Reducing Environmental Impact

    As the UN Climate Change Conference (COP27) convenes this month in Sharm el-Sheikh, Egypt, Sharon Vidal, global head of Corporate Social Responsibility at Illumina, talks to the company's chief technology officer, Alex Aravanis, about achieving a sustainable future with intelligent data storage solutions that reduce Illumina's environmental footprint.

Advertisement
Advertisement